1. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
   Wei Liu et al, 2017, J Int Med Res CrossRef
2. miR-191/DAB2 Axis Regulates the Tumorigenicity of Estrogen Receptor-Positive Breast Cancer
   Xinxin Tian et al, 2017, IUBMB Life CrossRef
3. MicroRNA regulatory networks reflective of polyhexamethylene guanidine phosphate-induced fibrosis in A549 human alveolar adenocarcinoma cells
   Da Young Shin et al, 2018, Toxicology Letters CrossRef
4. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia
   Laixi Bi et al, 2018, BMC Cancer CrossRef
5. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
   Ramesh Butti et al, 2018, Mol Cancer CrossRef
6. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
   Yinghua Zhu et al, 2018, Nat Commun CrossRef
7. Role of HOX Genes in Stem Cell Differentiation and Cancer
   Seema Bhatlekar et al, 2018, Stem Cells International CrossRef
8. Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer
   Michela Coan et al, 2018, IJMS CrossRef
9. The Network of Non-coding RNAs in Cancer Drug Resistance
   Fabio Corrà et al, 2018, Front. Oncol. CrossRef
10. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression
    Huijuan Feng et al, 2019, J Cell Physiol CrossRef
11. Prevention of breast cancer by dietary polyphenols—role of cancer stem cells
    Hao-Feng Gu et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
12. miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.
    Xu-chen Cao, 0 CrossRef
13. A Case of Identity: HOX Genes in Normal and Cancer Stem Cells
    null Smith et al, 2019, Cancers CrossRef
14. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
    null Khan et al, 2019, Cells CrossRef
15. Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers
    Mohd Farhan et al, 2019 CrossRef
16. The role of upregulated miR-375 expression in breast cancer: an in vitro and in silico study
    Wei Tang et al, 2019, Pathology - Research and Practice CrossRef
17. Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer.
    Xiao Li et al, 2020, Int J Mol Sci CrossRef
18. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
    Dharambir Kashyap et al, 2020, Life Sciences CrossRef
19. HOX genes function in Breast Cancer development
    Simone Aparecida de Bessa Garcia et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
20. Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review
    Danielle Barbosa Brotto et al, 2020, Tumour Biol. CrossRef
21. Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
    Xiaorong Lin et al, 2020, Cell Reports CrossRef
22. Circ-PRKDC Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells by Regulating miR-375/FOXM1 Axis and Wnt/β-Catenin Pathway.
    Hao Chen et al, 2020, Onco Targets Ther CrossRef
23. Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer
    Chen Yan et al, 2019, Mol Med Report CrossRef
24. MicroRNA-10b-5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression.
    Weiling Li et al, 2019, Exp Ther Med CrossRef
25. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling
    Qiong Zhao et al, 2020, European Journal of Pharmacology CrossRef
26. miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers
    Yulei Wei et al, 2020, Breast Cancer CrossRef
27. Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer.
    Lizhe Zhu et al, 2020, PeerJ CrossRef
28. Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells
    Amelia Weber Hall et al, 2018, Cancer Res CrossRef
29. MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer.
    Tong Niu et al, 2021, Cancer Cell Int CrossRef
30. Signaling pathways governing breast cancer stem cells behavior.
    Kai Song et al, 2021, Stem Cell Res Ther CrossRef
31. The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer.
    Soudeh Ghafouri-Fard et al, 2021, Front Cell Dev Biol CrossRef
32. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer
    Jingjing Wu et al, 2021, Aging CrossRef
33. MicroRNAs as a clue to overcome breast cancer treatment resistance
    Iris Garrido-Cano et al, 2021, Cancer Metastasis Rev CrossRef
34. Downregulation of RPS14 inhibits the proliferation and metastasis of estrogen receptor-positive breast cancer cells
    Xiu Wang et al, 2021 CrossRef
35. Contribution of miRNAs in the Pathogenesis of Breast Cancer
    Soudeh Ghafouri-Fard et al, 2021, Front. Oncol. CrossRef
36. MicroRNA-375: potential cancer suppressor and therapeutic drug.
    Jiahui Wei et al, 2021, Biosci Rep CrossRef
37. Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway
    Zhaoxia Yu et al, 2022, Analytical Cellular Pathology CrossRef
38. Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
    Matthew G Davey et al, 2022, Breast Cancer�(Auckl) CrossRef
39. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
    Mehrdokht Sadrkhanloo et al, 2022, European Journal of Pharmacology CrossRef
40. Prognostic value of micro-RNA 375, 133, 143, 145 in esophageal carcinoma: A systematic review and meta-analysis
    Pinhao Fang et al, 2022, Front. Oncol. CrossRef
41. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis.
    Jiayun Liu et al, 2023, Environ Toxicol CrossRef
42. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions.
    Mehrdad Hashemi et al, 2022, Biomed Pharmacother CrossRef
43. The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy
    Lorena Alexandra Lisencu et al, 2022, Medicina CrossRef
44. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
    Nina Petrović et al, 2021, J Mammary Gland Biol Neoplasia CrossRef
45. RNA interference: Promising approach for breast cancer diagnosis and treatment
    Elham Allahyari et al, 2022, Cell Biology International CrossRef
46. The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs
    Mine Ensoy et al, 2023, CMC CrossRef
47. Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
    Risheng He et al, 2023, Cancers CrossRef
48. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer
    Luis M. Ruiz-Manriquez et al, 2023, IJMS CrossRef
49. MicroRNAs as a theranostics: combating breast cancer stem cells
    Meghavi Kathpalia et al, 2024 CrossRef
50. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
    Peng Xing et al, 2023, Drug Resistance Updates CrossRef
51. The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: biological mechanisms and future potential
    Alireza Mafi et al, 2024, Pathology - Research and Practice CrossRef
52. Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis
    Xiaogang Li et al, 2024, PLoS ONE CrossRef
53. LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p/STK4 pathway in prostate cancer
    Ting-Ting Lu et al, 2022 CrossRef
54. STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression
    Laigang Zhao et al, 2024, Commun Biol CrossRef
55. miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer
    Bin Ouyang et al, 2024, Cancers CrossRef